| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Sabino Recovery specializes in the treatment of trauma and its resulting symptoms. Our 35 day residential treatment center is a place to heal from childhood or adult trauma, PTSD, anxiety, depression, substance abuse, and addictions. Our program works ...
Shodair Children's Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Helena, MT. To find more information about Shodair Children's Hospital, please visit www.shodair.org
Precept Medical Communications is a Warren, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Image Owl creates complete, convenient , accurate and insightful cloud-based solutions to analyze and manage your diagnostic medical imaging and radiotherapy quality assurance needs.